ClearBridge Investments’s Tarsus Pharmaceuticals TARS Stock Holding History

ClearBridge Investments’s Portfolio TARS Stock Details TARS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$34.6M	Buy	549,387 +4,036	+0.7%	+$258K	0.03%	374
2026 Q1	$38.3M	Buy	545,351 +39,262	+8%	+$2.74M	0.03%	349
2025 Q4	$41.4M	Sell	506,089 -60,889	-11%	-$4.55M	0.03%	353
2025 Q3	$33.7M	Buy	566,978 +122,476	+28%	+$6.03M	0.03%	382
2025 Q2	$18M	Buy	+444,502	New	+$20M	0.01%	429
2024 Q4	–	Sell	-191,374	Closed	-$6.29M	–	743
2024 Q3	$6.29M	Buy	+191,374	New	+$5.38M	﹤0.01%	565

Other funds holding TARS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

ClearBridge Investments's TARS Position: Q2 2026 in Review

ClearBridge Investments increased its Tarsus Pharmaceuticals (TARS) stake by 0.74% in Q2 2026, buying an estimated $258K and bringing the position to 549,387 shares worth $34.6M. The position accounts for 0.03% of the portfolio, ranked #374.

ClearBridge Investments first reported a position in TARS in Q3 2024 and has held it in 6 quarters since. The position peaked at $41.4M in Q4 2025. 168 funds tracked by Wall St. Rank hold TARS as of Q2 2026.

ClearBridge Investments held 549,387 shares of Tarsus Pharmaceuticals worth $34.6M as of Q2 2026.
ClearBridge Investments bought 4,036 Tarsus Pharmaceuticals shares in Q2 2026, an estimated $258K.
Tarsus Pharmaceuticals made up 0.03% of ClearBridge Investments's portfolio in Q2 2026, its #374 holding.
ClearBridge Investments first reported a position in Tarsus Pharmaceuticals in Q3 2024 and has held it in 6 quarters since.
ClearBridge Investments's Tarsus Pharmaceuticals position peaked at $41.4M in Q4 2025.
168 funds tracked by Wall St. Rank held Tarsus Pharmaceuticals as of Q2 2026.

Based on ClearBridge Investments's 13F filing for Q2 2026, filed 13 Aug 2026.